Detalhe da pesquisa
1.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724563
2.
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting.
Br J Haematol
; 190(6): 891-900, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239670
3.
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Br J Haematol
; 185(1): 42-52, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592027
4.
Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus.
Blood
; 129(3): 319-323, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27827825
5.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
6.
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Lancet Oncol
; 18(4): 454-463, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236583
7.
Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications.
J Am Chem Soc
; 139(6): 2512-2519, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097863
8.
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.
Int J Cancer
; 137(9): 2083-92, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912930
9.
The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia.
Haematologica
; 105(6): e285-e289, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558674
10.
The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype.
Blood
; 119(19): 4383-6, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22374696
11.
High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia.
Blood
; 120(10): 2118-26, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22815426
12.
Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
Cancer Cell
; 10(5): 363-74, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17097559
13.
The vent-like homeobox gene VENTX promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 107(39): 16946-51, 2010 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20833819
14.
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
Ann Hematol
; 91(1): 9-18, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21744003
15.
Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
Genes Chromosomes Cancer
; 50(7): 546-58, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21500311
16.
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).
Blood
; 113(21): 5250-3, 2009 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19279329
17.
TET1 promotes growth of T-cell acute lymphoblastic leukemia and can be antagonized via PARP inhibition.
Leukemia
; 35(2): 389-403, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409690
18.
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
Lancet Haematol
; 8(6): e398-e409, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048679
19.
Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis.
Sci Rep
; 10(1): 371, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941913
20.
Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
Leukemia
; 34(4): 1027-1037, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758089